Adalimumab-ryvk Kit shortage

To Be Discontinued

Adalimumab-ryvk Kit is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Rheumatology

Dosage form

—

Routes

—

Last updated

11/13/2025

Strength variants

Not specified

Need sourcing help for Adalimumab-ryvk Kit?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Teva Pharmaceuticals USA, Inc.800-545-8800
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

Related shortages in Rheumatology

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Demand increase for the drug
Updated: 04/08/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Demand increase for the drug
Updated: 04/08/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Demand increase for the drug
Updated: 04/07/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Not specified
Updated: 04/06/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Not specified
Updated: 04/06/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Shortage of an active ingredient
Updated: 04/06/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.